Ranitidine 25mg Injection PCD Franchise in Ahmedabad

GERD & Acid Reflux Injectable Supplier in Bangalore

Ranitidine Injection Distributor in Hyderabad

Peptic Ulcer & Hyperacidity Injectable Franchise Opportunity in Jaipur

Ranitidine 25mg Injection Stockist in Mumbai
H2 Receptor Antagonist Injection Export and Manufacturing in Chandigarh

Home/Products /ranitidine-25-mg-injection

About the Product

Description


Ranilair 25 Injection contains Ranitidine 25mg, an H2 receptor antagonist widely used to reduce stomach acid and manage gastrointestinal disorders such as GERD, acid reflux, and peptic ulcers. Its precise formulation ensures rapid and reliable relief in hospital and clinical settings.

The injection works by blocking H2 receptors in the stomach lining, decreasing gastric acid secretion, and promoting healing of the gastrointestinal mucosa. It is suitable for patients who require fast-acting, injectable treatment for hyperacidity-related conditions.

For suppliers, Ranilair 25 Injection is a high-demand injectable product with consistent hospital and clinical usage, making it a reliable addition to any gastrointestinal or hospital portfolio. Its therapeutic relevance ensures repeated demand from healthcare providers.

By including Ranilair 25 Injection in your product range, distributors can enhance brand credibility, ensure strong turnover, and access the growing market of gastroenterology injectables, offering an attractive opportunity for business expansion and increased profitability.

Some patients may experience headache, dizziness, constipation, diarrhea, or mild nausea. Rarely, allergic reactions, arrhythmias, or liver function abnormalities may occur.

Ranilair 25 Injection is indicated for the treatment of gastroesophageal reflux disease (GERD), peptic ulcers, Zollinger-Ellison syndrome, and other conditions associated with excessive stomach acid. It is also used to prevent acid aspiration during surgery.

Use only under medical supervision. Avoid in patients with known hypersensitivity to ranitidine or severe liver/kidney impairment. Administer the dose as prescribed and monitor for side effects.

Store in a cool, dry place below 25°C, protected from light and moisture. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Ranitidine 25mg Injection in the PCD pharma franchise market?

Ranitidine 25mg Injection has demand in the gastroenterology, hospital care, emergency care, and general medicine segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on gastrointestinal and hospital care portfolios.

Why should medical distributors include Ranitidine 25mg Injection in their product range?

Medical distributors and agencies can benefit from demand for acid-related gastrointestinal disorder management in hospital settings under medical supervision. Ranitidine 25mg Injection is an H2-receptor antagonist that helps reduce gastric acid secretion Traditionally used in the management of acid peptic disorders, gastroesophageal reflux disease (GERD), stress ulcer prophylaxis, and other acid-related conditions as advised by healthcare professionals Injectable formulation enables administration in hospitalized patients when oral therapy may not be suitable Frequently utilized in hospitals, emergency departments, surgical units, and critical care settings Requires administration and monitoring by qualified healthcare professionals Supports comprehensive gastrointestinal care in institutional healthcare environments This strengthens a comprehensive gastroenterology and hospital care portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this product?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Ranitidine 25mg Injection with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from institutional demand, hospital procurement opportunities, reliable supply chain support, repeat orders, and attractive margins in the hospital care segment.

How can I become a distributor or franchise partner for this product?

Interested distributors, stockists, and wholesalers can partner with Cafoli LifeCare Pvt Ltd to access lucrative PCD pharma franchise opportunities across India. With exclusive monopoly rights, extensive promotional support, high-quality pharmaceutical products, attractive business margins, and dependable logistics support, Cafoli LifeCare Pvt Ltd helps franchise partners build a successful and profitable pharmaceutical business.